Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP885168.RA1Ch25nf_lYOiZo-XlijZov3kZsgFmlwvDf6MoIT1i5Y130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP885168.RA1Ch25nf_lYOiZo-XlijZov3kZsgFmlwvDf6MoIT1i5Y130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP885168.RA1Ch25nf_lYOiZo-XlijZov3kZsgFmlwvDf6MoIT1i5Y130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP885168.RA1Ch25nf_lYOiZo-XlijZov3kZsgFmlwvDf6MoIT1i5Y130_provenance.
- befree-2016 importedOn "2016-02-19" NP885168.RA1Ch25nf_lYOiZo-XlijZov3kZsgFmlwvDf6MoIT1i5Y130_provenance.
- NP885168.RA1Ch25nf_lYOiZo-XlijZov3kZsgFmlwvDf6MoIT1i5Y130_assertion wasGeneratedBy ECO_0000203 NP885168.RA1Ch25nf_lYOiZo-XlijZov3kZsgFmlwvDf6MoIT1i5Y130_provenance.
- NP885168.RA1Ch25nf_lYOiZo-XlijZov3kZsgFmlwvDf6MoIT1i5Y130_assertion wasDerivedFrom befree-2016 NP885168.RA1Ch25nf_lYOiZo-XlijZov3kZsgFmlwvDf6MoIT1i5Y130_provenance.
- NP885168.RA1Ch25nf_lYOiZo-XlijZov3kZsgFmlwvDf6MoIT1i5Y130_assertion SIO_000772 21471514 NP885168.RA1Ch25nf_lYOiZo-XlijZov3kZsgFmlwvDf6MoIT1i5Y130_provenance.
- NP885168.RA1Ch25nf_lYOiZo-XlijZov3kZsgFmlwvDf6MoIT1i5Y130_assertion evidence source_evidence_literature NP885168.RA1Ch25nf_lYOiZo-XlijZov3kZsgFmlwvDf6MoIT1i5Y130_provenance.
- NP885168.RA1Ch25nf_lYOiZo-XlijZov3kZsgFmlwvDf6MoIT1i5Y130_assertion description "[Interestingly, reducing ChREBP(OG) levels via OGA overexpression decreased lipogenic protein content (ACC, FAS), prevented hepatic steatosis, and improved the lipidic profile of OGA-treated db/db mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP885168.RA1Ch25nf_lYOiZo-XlijZov3kZsgFmlwvDf6MoIT1i5Y130_provenance.